Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Rachael Z Stolzenberg-SolomonAndriy DerkachSteven MooreStephanie J WeinsteinDemetrius AlbanesJoshua SampsonPublished in: Gut (2020)
Our results suggest that prediagnostic metabolites related to subclinical disease, γ-glutamyl cycle metabolism and adiposity/insulin resistance are associated with PDAC.